Standard Social Media Practices Are Risky For Big Pharma

As the pharma industry comes late to social media, FDA guidance and regulation of pharma’s efforts illustrate difficulties industry may face.

September 26, 2014

Law360, New York (September 26, 2014, 10:08 AM ET) --

The days of patients relying solely on family physicians for health care information are long gone. As with many things, when we need information about an illness or a medical condition, we turn to "the Google." And though most online health queries begin at a search engine, a not-insignificant number start somewhere else, such as Wikipedia. Those who are Internet-savvy tend to be avid social media users, spending more time with their social networks than on email, especially with their Facebook friends. An estimated 200,000 people are likely to start there if they have a question.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.


Related Publications

December 8, 2022
Lessons From MMAS Research About Dispositive Pitfalls in Copyright Litigation
David Martinez, Austin Miller - Los Angeles & San Francisco Daily Journal
November 19, 2022
How to Use the USPTO Patent Public Search Tool
Miles Finn, Rajin Olson, Kelson Bain, and Ian LaForge - IPWatchdog
October 2022
In No Uncertain Terms
Bryan Mechell - The Robins Kaplan Quarterly
September 13, 2022
Patent Value: Scoring Patents Using Characteristics Of Patents In Litigation
Christopher K. Larus, Miles A. Finn, Congnan Zhan, Joseph (Yu) Chen, and Shelley Gilliss - les Nouvelles
September 2, 2022
Trade Dress Through a Trial Lens: Six Strategy Tips For Litigants
Christopher Larus, William Manske - Managing IP
Back to Top